Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Category | Equity ETFs | Equity ETFs |
| Plan | Direct | Direct |
| Fund house | Nippon India | Nippon India |
| NAV | ₹149.5121 | ₹29.1863 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 11.4 years | 5.4 years |
| Expense ratio | 0.4% | 0.2% |
| Stars | Not rated | Not rated |
| Growth Score | — | — |
Returns
| Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 1 month | +11.26% | +10.82% |
| 3 months | +6.95% | +7.43% |
| 6 months | +6.02% | +14.54% |
| YTD | −3.83% | +25.40% |
| 1 year | −2.66% | +25.57% |
| 3 years (CAGR) | +7.72% | +22.02% |
| 5 years (CAGR) | +8.80% | +16.60% |
| 10 years (CAGR) | +15.22% | — |
| Since launch | +12.89% | +14.02% |
Risk
| Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Volatility | 15.3% | 15.0% |
| Downside volatility | 10.5% | 9.0% |
| Sharpe | 0.08 | 1.04 |
| Sortino | 0.12 | 1.72 |
| Calmar | 0.34 | 1.33 |
| Return / risk | 0.50 | 1.47 |
| Deepest fall | −30.30% | −20.98% |
| Days to recover | 147 | 136 |
| Below its high | −10.65% | −1.75% |
Against benchmark
| Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Alpha | +0.00% | +0.00% |
| Beta | 1.00 | 1.00 |
| R² | 100.0% | 100.0% |
| Up capture | 100.0% | 100.0% |
| Down capture | 100.0% | 100.0% |
| Tracking error | 0.0% | 0.0% |
| Information ratio | — | — |
| Treynor | 0.01 | 0.14 |
Consistency
| Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Best 1-year | +92.37% | +65.21% |
| Middle 1-year | +13.13% | +13.46% |
| Worst 1-year | −27.56% | −15.30% |
| 1-year periods with a loss | 18.6% | 25.8% |
| Middle 3-year | +17.10% | +20.51% |
| Positive months | 58.3% | 61.1% |
| Best day | +4.32% | +3.64% |
| Worst day | −5.79% | −4.03% |
| Worst 5% day | −1.23% | −1.62% |
| Positive days | 51.1% | 54.4% |
| NAVs a year | 248 | 248 |
SIP of ₹10,000 a month
| Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| 5-year XIRR | +7.30% | +20.60% |
| 5-year value | ₹7,24,061 | ₹10,11,738 |
| 3-year XIRR | +2.07% | +19.58% |
| 1-year XIRR | +5.83% | +34.31% |
Holdings overlap i
| Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Nippon India ETF Nifty 50 Value 20 | — | 1% |
| Nippon India Nifty Pharma ETF | 1% | — |
Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.
Held by all of them
| Stock | Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF |
|---|---|---|
| Dr. Reddy's Laboratories Limited | 1.08% | 8.15% |
Sectors and company size
| Nippon India ETF Nifty 50 Value 20 | Nippon India Nifty Pharma ETF | |
|---|---|---|
| Large companies | 98.9% | 45.3% |
| Mid companies | 1.1% | 47.1% |
| Small companies | — | 7.6% |
| Top 10 holdings | 77.4% | 78.6% |
| Largest sector | Banks 44% | Pharmaceuticals & Biotechnology 100% |